Zoetis Inc. (NYSE:ZTS) Q1 2024 Earnings Call Transcript
Zoetis Inc. beats earnings expectations. Reported EPS is $1.38, expectations were $1.35. Zoetis Inc.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cantillon Capital Management William Von Mueffling | 1,392,262 | $235,584,653 | -2% | 1.48% |
| 2. | Bristol Gate Capital Partners Peter Simmie | 472,602 | $79,968,984 | -1% | 3.75% |
| 3. | Impax Asset Management Ian Simm | 77,344 | $13,087,378 | +10% | 0.05% |
| 4. | Bailard Inc Thomas Bailard | 68,086 | $11,520,832 | +1% | 0.31% |
| 5. | Entropy Technologies Vikram Modi And Arjun Modi | 44,014 | $7,447,609 | 0.79% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | Director | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | Director | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | Director | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | Director | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | Director | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $151.17 | 923 | Officer | 14,800 | 2024-04-18 | Filing | |
| $173.33 | 923 | Officer | 15,723 | 2024-03-18 | Filing | |
| $182.68 | 1,370 | Director | 9,994 | 2024-03-11 | Filing | |
| $187.20 | 13,000 | Officer, Director | 79,366 | 2024-02-20 | Filing | |
| $187.30 | 923 | Officer | 16,646 | 2024-02-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 40,334,966 | $7,960,912,239 | 0.17% | |
| 2. | 36,493,861 | $7,202,793,380 | 0.18% | |
| 3. | 19,322,219 | $3,813,626,364 | 0.18% | |
| 4. | 16,344,542 | $3,225,922,255 | 3.1% | |
| 5. | 14,676,576 | $2,896,699,739 | 0.64% |
News See All
10 Most Promising Stocks to Buy Before They Take Off
In this article, we discuss the 10 most promising stocks to buy before they take off.
5 Oversold Growth Stocks to Buy Right Now
In this article, we will take a look at the 5 oversold growth stocks to buy right now.
14 Dividend Growth Stocks with Highest Growth Rates
In this article, we discuss 14 dividend growth stocks with highest growth rates.
Zoetis (ZTS) Fell After Reporting Mixed Fourth Quarter Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Zoetis (ZTS) Fell on Slower Veterinary Visits
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here.
5 Best Dividend Stocks with High Upside Potential
In this article, we discuss 5 best dividend stocks with high upside potential.
Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks
In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.
12 Best S&P 500 Stocks To Buy According to Analysts
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts.
11 Oversold Blue Chip Stocks to Buy Right Now
In this article, we will take a look at the 11 oversold blue chip stocks to buy right now.
Billionaire Hedge Funds
